Cell therapy · Banking

Stem cell banking:
a one-time decision.

A newborn’s cord blood, cord tissue, placenta and immune cells are the youngest, most potent cells your family will ever have access to — and they can only be collected at birth. Banked at -196°C through licensed facilities, with honest expectations about what they can and can’t do.

Once

One-time opportunity

Collected only at birth — never again

Biology

4

Perinatal sources

Cord blood · cord tissue · placenta · immune cells

Cell banking

-196°C

Cryostorage

Liquid nitrogen, long-term viability

Bank standard

Whole family

Potential beneficiaries

Low-immunogenicity cells, broader use

Clinical practice

$2–6k

Upfront, + storage

Plus ~$150–400/year

Industry data

Licensed

Banks only

Properly licensed processing & storage

Panda Touring Care

Why it matters

The richest cells,
available once.

At birth, the umbilical cord, placenta and cord blood contain an exceptional concentration of both stem cells and immune cells — younger, more vigorous and less damaged than anything that can be harvested later in life. It is, quite literally, a gift available only at the moment of delivery.

Cord-tissue and placental mesenchymal stem cells are regarded as ideal “seed cells” for regenerative medicine; cord-blood immune cells are highly pure and, because of their low immunogenicity, can often be used across the family. Store once — the whole family may benefit.

We frame this honestly: banking is an insurance-style decision about future optionality. Some uses (certain blood and immune disorders) are established today; many regenerative applications remain investigational and are pursued through registered clinical research. Banking preserves the choice; it doesn’t promise a cure. The stored cells can later feed MSC therapy or immune-cell protocols.

What you can store

Six perinatal sources.

Haematopoietic + immune

Cord blood 脐带血

Rich in blood-forming (haematopoietic) stem cells and pure, low-immunogenicity immune cells. Established use in certain blood and immune disorders; the classic banking sample.

Regenerative

Cord tissue (MSC) 脐带间充质干细胞

Wharton's jelly is a leading source of mesenchymal stem cells — strong self-renewal, multi-lineage differentiation and immune modulation. The 'ideal seed cell' of regenerative medicine.

High yield

Placental MSC 胎盘间充质干细胞

Placenta-derived MSC are numerous, broadly applicable and low in immunogenicity, with strong migration-to-injury and tissue-regeneration potential.

Family-usable

Cord-blood immune cells 脐带血免疫细胞

Highly pure immune cells with high expansion capacity and low immunogenicity — can often be used across family members, not just the child.

For mother

Placental maternal MSC 胎盘母源干细胞

Maternal-side (decidua) MSC are genetically close to the mother — a tailored sample for post-partum recovery and women's-health research uses.

Reserve

Amniotic membrane 羊膜

Amniotic tissue is a further perinatal source studied for wound healing and ophthalmic/regenerative applications; banked alongside the main tissues where offered.

Why bank

Four honest reasons.

Timing

It's now or never

Perinatal cells can only be collected at birth. Unlike adult stem cells harvested later from marrow or fat, this exact, youngest, most-potent source is a one-time, non-repeatable opportunity.

Potency

Younger cells, better quality

Newborn cells are at their most vigorous — higher viability, stronger proliferation and lower accumulated damage than cells harvested in adulthood.

Reach

Whole-family insurance

Low immunogenicity means stored cord/placental and immune cells may serve siblings and parents — one decision that can protect more than one person.

Integrity

Honest expectations

We frame banking as preserving future optionality. Some uses are established today; many are investigational. We don't promise cures — we preserve the choice to use them if science and your family's needs align.

We work only with properly licensed cell banks and set honest expectations. Established clinical uses exist for some banked cells today; many regenerative and immune applications remain investigational and are accessed through registered clinical research. Banking preserves future optionality — it is not a guarantee of treatment for any specific condition.

The process

From decision
to cryostorage.

Step 1

Decide before delivery

Choose which tissues to bank (cord blood, cord tissue, placenta, immune cells) and sign the storage agreement ahead of the due date. We arrange the licensed bank and collection kit.

Step 2

Collection at birth

After delivery and cord clamping, the medical team collects cord blood and cord/placental tissue from the separated, otherwise-discarded material — no added risk to mother or baby.

Step 3

Processing & testing

Samples are transported under controlled conditions to a licensed lab for separation, viability and identity testing, microbial screening and characterisation before storage.

Step 4

Cryopreservation

Validated samples are cryopreserved at -196°C in liquid nitrogen with documented chain-of-custody and a long-term storage contract.

Step 5

Future retrieval

If a clinical need arises, samples are matched (HLA and other testing) and released for use in established treatment or registered clinical research, coordinated with your physician.

FAQ

Stem cell banking, answered.

What is stem cell banking?
Stem cell banking (cell storage) is the collection, processing, quality testing and cryopreservation of cells at -196°C in liquid nitrogen so they're available if needed in the future. The richest one-time source is a newborn's perinatal tissue at birth: umbilical cord blood, umbilical cord tissue (Wharton's jelly), placenta and the cord-blood immune cells. Once the moment of birth passes, these specific cells can never be collected again — which is why families decide in advance.
What types of newborn cells can be banked?
Four main sources: (1) Umbilical cord blood — rich in haematopoietic and immune cells; (2) Umbilical cord tissue (Wharton's jelly) — a leading source of mesenchymal stem cells (MSC) with strong regenerative and immune-modulating potential; (3) Placental tissue — placenta-derived MSC are numerous, broadly applicable and low in immunogenicity; (4) Cord-blood immune cells — highly pure, low-immunogenicity immune cells that can be used across family members. Together they cover both regenerative (stem) and defensive (immune) needs.
Who can use banked newborn cells — just the child?
Not only the child. A key advantage of perinatal cells is low immunogenicity and good tissue compatibility, so stored cord-blood immune cells and cord/placental MSC can often be used by siblings and parents too — 'store once, the whole family may benefit'. Cord-blood haematopoietic cells are most likely a match for the child and siblings. Exact compatibility is confirmed by HLA and other testing at the time of any future use.
What could banked cells be used for in the future?
Honestly: this is an insurance-style decision about future optionality, not a guarantee of treatment. Cord-blood stem cells already have established use in certain blood and immune disorders. Cord/placental MSC and cord-blood immune cells are being studied across a wide range of regenerative and immune indications and are used in registered clinical research. We are explicit that many applications remain investigational — banking preserves the option; it does not promise a specific cure.
How much does stem cell banking cost in China?
Typical pricing: an upfront collection-and-processing fee of roughly $2,000–$6,000 depending on which tissues you bank and the testing package, plus an annual storage fee of about $150–$400/year (often discounted with multi-year or lifetime prepayment). Banking multiple tissue types (cord blood + cord tissue + placenta) costs more upfront but captures the full one-time opportunity. Request an itemized quote.
Is the collection safe for mother and baby?
Yes. Collection happens after the baby is delivered and the cord is clamped — cord blood is drawn from the already-separated umbilical cord, and cord/placental tissue is taken from tissue that is otherwise discarded. The process does not interfere with delivery and poses no added risk to mother or baby. Samples are then transported under controlled conditions to a licensed processing lab.
Can international families bank newborn cells in China?
Yes, where the birth takes place in China or where licensed cross-border logistics allow sample transport. Panda Touring Care coordinates the licensed bank, collection kit, timing around delivery, processing, quality testing and long-term storage contract. We work only with properly licensed cell banks and set honest expectations about current versus future clinical uses.

Planning a birth
in China?

Talk to a coordinator about licensed cord blood, cord tissue and placenta banking — what to store, what it costs, and honest guidance on current versus future clinical uses. Decisions are best made before the due date.